MaxCyte 公司
US ˙ NasdaqGS ˙ US57777K1060

SecurityMXCT / MaxCyte, Inc.
InstitutionRoyce Micro-cap Trust, Inc /md/
Latest Disclosed Ownership480,404 shares
Latest Disclosed Value $ 1,047,280
Royce Micro-cap Trust, Inc /md/ reports 41.33% decrease in ownership of MXCT / MaxCyte, Inc.

On August 15, 2025 - Royce Micro-cap Trust, Inc /md/ filed a NPORT-P form disclosing ownership of 480,404 shares of MaxCyte, Inc. (US:MXCT) valued at $1,047,281 USD as of June 30, 2025. The entity filed a previous NPORT-P on May 19, 2025 disclosing 818,873 shares of MaxCyte, Inc.. This represents a change in shares of -41.33% during the quarter. The current value of the position is $547,661 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2025-08-15 2025-06-30 NP MaxCyte EC US57777K1060 480,404 -338,469 -41.33 1,047 -53.15 0.1885
2025-05-19 2025-03-31 NP MaxCyte EC US57777K1060 818,873 19,000 2.38 2,236 -32.82 0.4579
2025-02-21 2024-12-31 NP MaxCyte EC US57777K1060 799,873 475,949 146.93 3,327 164.05 0.5871
2024-11-19 2024-09-30 NP MaxCyte EC US57777K1060 323,924 121,272 59.84 1,260 58.69 0.2273
2024-08-12 2024-06-30 NP MaxCyte EC US57777K1060 202,652 121,224 148.87 794 132.84 0.1484
2024-05-28 2024-03-31 NP MaxCyte EC US57777K1060 81,428 -64,009 -44.01 341 -50.07 0.0632
2024-02-20 2023-12-31 NP MaxCyte EC US57777K1060 145,437 -27,123 -15.72 684 26.95 0.1313
2023-11-22 2023-09-30 NP MaxCyte EC US57777K1060 172,560 23,780 15.98 538 -21.11 0.1150
2023-08-09 2023-06-30 NP MaxCyte EC US57777K1060 148,780 50,855 51.93 683 40.91 0.1405
2023-05-19 2023-03-31 NP MaxCyte EC US57777K1060 97,925 47,800 95.36 485 77.29 0.1024
2023-02-21 2022-12-31 NP MaxCyte EC US57777K1060 50,125 38,800 342.60 274 273.97 0.0587
2022-11-17 2022-09-30 NP MaxCyte EC US57777K1060 11,325 11,325 74 0.0174
2022-08-16 2022-06-30 NP MaxCyte EC US57777K1060 0 -131,698 -100.00 0 -100.00
2022-05-16 2022-03-31 NP MaxCyte EC US57777K1060 131,698 -10,202 -7.19 921 -36.33 0.1704
2022-02-24 2021-12-31 NP MaxCyte EC US57777K1060 141,900 11,900 9.15 1,446 -8.95 0.2449
2021-11-22 2021-09-30 NP MaxCyte EC US57777K1060 130,000 130,000 1,587 0.2735
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.